BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12772817)

  • 1. Efficacy of a herbal preparation in patients with functional dyspepsia: a meta-analysis of double-blind, randomized, clinical trials.
    Gundermann KJ; Godehardt E; Ulbrich M
    Adv Ther; 2003; 20(1):43-9. PubMed ID: 12772817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The efficacy of a combination herbal medicine in the treatment of functional dyspepsia. Meta-analysis of randomized double-blind studies on the basis of a valid gastrointestinal symptom profile].
    Gundermann KJ; Godehardt E; Ulbrich M
    MMW Fortschr Med; 2004 Aug; 146 Suppl 2():71-6. PubMed ID: 16739362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia.
    Rösch W; Vinson B; Sassin I
    Z Gastroenterol; 2002 Jun; 40(6):401-8. PubMed ID: 12055663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.
    Rösch W; Liebregts T; Gundermann KJ; Vinson B; Holtmann G
    Phytomedicine; 2006; 13 Suppl 5():114-21. PubMed ID: 16978851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast).
    Melzer J; Rösch W; Reichling J; Brignoli R; Saller R
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1279-87. PubMed ID: 15606389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iberis amara L. and Iberogast--results of a systematic review concerning functional dyspepsia.
    Melzer J; Iten F; Reichling J; Saller R
    J Herb Pharmacother; 2004; 4(4):51-9. PubMed ID: 15927925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study].
    Madisch A; Melderis H; Mayr G; Sassin I; Hotz J
    Z Gastroenterol; 2001 Jul; 39(7):511-7. PubMed ID: 11505331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Iberogast: a modern phytotherapeutic combined herbal drug for the treatment of functional disorders of the gastrointestinal tract (dyspepsia, irritable bowel syndrome)--from phytomedicine to "evidence based phytotherapy." A systematic review].
    Saller R; Pfister-Hotz G; Iten F; Melzer J; Reichling J
    Forsch Komplementarmed Klass Naturheilkd; 2002 Dec; 9 Suppl 1():1-20. PubMed ID: 12618546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STW 5 (Iberogast®)--a safe and effective standard in the treatment of functional gastrointestinal disorders.
    Ottillinger B; Storr M; Malfertheiner P; Allescher HD
    Wien Med Wochenschr; 2013 Feb; 163(3-4):65-72. PubMed ID: 23263639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia.
    Holtmann G; Gschossmann J; Mayr P; Talley NJ
    Aliment Pharmacol Ther; 2002 Sep; 16(9):1641-8. PubMed ID: 12197843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial.
    Holtmann G; Adam B; Haag S; Collet W; Grünewald E; Windeck T
    Aliment Pharmacol Ther; 2003 Dec; 18(11-12):1099-105. PubMed ID: 14653829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evidence-based medicine and phytotherapy for functional dyspepsia and irritable bowel syndrome: a systematic analysis of evidence for the herbal preparation Iberogast].
    Holtmann G; Adam B; Vinson B
    Wien Med Wochenschr; 2004 Nov; 154(21-22):528-34. PubMed ID: 15638072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [STW 5/Iberogast: multi-target-action for treatment of functional dyspepsia and irritable bowel syndrome].
    Allescher HD; Wagner H
    Wien Med Wochenschr; 2007; 157(13-14):301-7. PubMed ID: 17704976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study.
    Van Outryve M; De Nutte N; Van Eeghem P; Gooris JP
    Scand J Gastroenterol Suppl; 1993; 195():47-52; discussion 52-3. PubMed ID: 8516658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group.
    Champion MC; MacCannell KL; Thomson AB; Tanton R; Eberhard S; Sullivan SN; Archambault A
    Can J Gastroenterol; 1997 Mar; 11(2):127-34. PubMed ID: 9113812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of functional dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to cisapride. A multicenter, reference-controlled double-blind equivalence study.
    Madisch A; Heydenreich CJ; Wieland V; Hufnagel R; Hotz J
    Arzneimittelforschung; 1999 Nov; 49(11):925-32. PubMed ID: 10604046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of functional dyspepsia with a herbal preparation. A double-blind, randomized, placebo-controlled, multicenter trial.
    Madisch A; Holtmann G; Mayr G; Vinson B; Hotz J
    Digestion; 2004; 69(1):45-52. PubMed ID: 14755152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical study on safety and efficacy of Naesohwajung-tang on functional dyspepsia.
    Ha NY; Kim S; Ko SJ; Park JW; Kim J
    Medicine (Baltimore); 2020 May; 99(21):e19910. PubMed ID: 32481255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, randomized, placebo-controlled trial of cisapride in Saudi Arabs with functional dyspepsia.
    al-Quorain A; Larbi EB; al-Shedoki F
    Scand J Gastroenterol; 1995 Jun; 30(6):531-4. PubMed ID: 7569759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of cisapride on dysmotility-like functional dyspepsia: reduction of the fasting and postprandial area, but not of the postprandial antral expansion.
    Eberl T; Barnert J; Dumitrascu DL; Fischer J; Wienbeck M
    Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):991-5. PubMed ID: 9895043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.